Results 11 to 20 of about 134,430 (328)

Metastatic Basal Cell Carcinoma of the Eyelid

Delhi Journal of Ophthalmology, 2014
Metastatic basal cell carcinoma (MBCC) arising from the eyelid is a very rare entity. We describe a case of a 65 year old female who presented to us with a mass lesion on the left upper eyelid.
Bhavna Chawla, Anoop Gupta, Seema Sen, Mandeep S. Bajaj   +3 more
doaj   +2 more sources

Incidental detection of rare metastatic basal cell carcinoma on screening mammography [PDF]

Radiology Case Reports
Basal cell carcinoma (BCC) is the most common nonmelanoma skin cancer but rarely metastasizes, with an estimated metastatic rate of 0.1%. Metastatic spread to axillary lymph nodes is extremely uncommon, and to our knowledge, no prior cases have reported ...
Alexandra DiTommaso, BS, Ciera Mangone, MD, Ashley Cimino-Mathews, MD, Babita Panigrahi, MD   +3 more
doaj   +2 more sources

Metastatic basal cell carcinoma to the lungs: Case report and review of literature [PDF]

Indian Dermatology Online Journal, 2014
Basal cell carcinoma is the most common form of skin cancer and it rarely metastasizes. The prevalence of metastatic basal cell carcinoma (MBCC) varies between 0.0028% and 0.55% of all cases. Over 250 MBCC have been reported in the literature. We present
Henry Benson Nongrum, Debomaliya Bhuyan, Vanlalhuma Royte, Hughbert Dkhar   +3 more
doaj   +2 more sources

Dual anti-CTLA-4 and anti-PD-1 blockade in metastatic basal cell carcinoma [PDF]

npj Precision Oncology
We report the basal cell cancer (BCC) cohort of the SWOG/NCI 1609 Dual Anti-CTLA-4 & Anti-PD-1 blockade in Rare Tumors (DART), a phase II prospective, multicenter basket trial of nivolumab and ipilimumab. The primary endpoint was objective response rate (
Sandip P. Patel, Eleanor Cano-Linson, Young Kwang Chae, Shiruyeh Schokrpur, Christopher D. Lao, Benjamin C. Powers, Adrienne I. Victor, Adedayo A. Onitilo, Sarah Shin, Naoko Takebe, Sara Threlkel, Christine M. McLeod, Helen X. Chen, Elad Sharon, Megan Othus, Christopher W. Ryan, Charles D. Blanke, Razelle Kurzrock   +17 more
doaj   +2 more sources

Genomic tumor studies aid in diagnosing metastatic basal cell carcinoma: A case series [PDF]

JAAD Case Reports, 2021
Kylee J.B. Kus, BS, Emily S. Ruiz, MD, MPH   +1 more
doaj   +2 more sources

Metastatic Basal Cell Carcinoma: A Rare Manifestation of a Common Disease [PDF]

Case Reports in Medicine, 2017
Introduction. Basal cell carcinoma (BCC) is considered the most common malignancy in Caucasians. It constituted about 80% of all nonmelanoma skin tumors and, despite its high prevalence, is an extremely rare occurrence of metastases, with incidence rates
Paola Piva de Freitas, César Galusni Senna, Mayara Tabai, Carlos Takahiro Chone, Albina Altemani   +4 more
doaj   +2 more sources

18F-FDG PET/CT Monitoring of Response to Programmed Death Protein 1 Blockade in Metastatic Basal Cell Carcinoma. [PDF]

Clin Nucl Med, 2021
Jadvar H, In GK.
europepmc   +3 more sources

Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma. [PDF]

JAMA Dermatol, 2016
Ally MS, Ransohoff K, Sarin K, Atwood SX, Rezaee M, Bailey-Healy I, Kim J, Beachy PA, Chang AL, Oro A, Tang JY, Colevas AD.   +11 more
europepmc   +3 more sources

Metastatic basal cell carcinoma with loss of p63 and mismatch repair proteins [PDF]

JAAD Case Reports, 2017
Nathan M. Johnson, MS, Alex C. Holliday, MD, David T. Luyimbazi, MD, Mariana A. Phillips, MD, George R. Collins, DO, Douglas J. Grider, MD   +5 more
doaj   +2 more sources

Metastatic basal cell carcinoma caused by carcinoma misdiagnosed as acne - case report and literature review. [PDF]

Clin Case Rep, 2016
Aydin D, Hölmich LR, Jakobsen LP.
europepmc   +3 more sources